These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22294394)

  • 21. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of the 5-HT receptor-mediated contraction in the mouse isolated ileum.
    Tuladhar BR; Womack MD; Naylor RJ
    Br J Pharmacol; 2000 Dec; 131(8):1716-22. PubMed ID: 11139451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats.
    Smriga M; Torii K
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15370-5. PubMed ID: 14676321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the interaction of histamine with the tryptaminergic smooth-muscle receptors.
    Todorov S; Petkov V
    Acta Physiol Pharmacol Bulg; 1980; 6(4):47-54. PubMed ID: 7324986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of angiotensin II receptors in smooth muscle preparations of the guinea pig in vitro.
    Leung E; Rapp JM; Walsh LK; Zeitung KD; Eglen RM
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1521-8. PubMed ID: 8263814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro opioid receptor assays.
    Taylor DA
    Curr Protoc Pharmacol; 2011 Dec; Chapter 4():Unit 4.8.1-34. PubMed ID: 22147348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
    Stollak JS; Furchgott RF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):215-21. PubMed ID: 6129317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan.
    Nelson DL; Phebus LA; Johnson KW; Wainscott DB; Cohen ML; Calligaro DO; Xu YC
    Cephalalgia; 2010 Oct; 30(10):1159-69. PubMed ID: 20855361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor.
    Wainscott DB; Cohen ML; Schenck KW; Audia JE; Nissen JS; Baez M; Kursar JD; Lucaites VL; Nelson DL
    Mol Pharmacol; 1993 Mar; 43(3):419-26. PubMed ID: 8450835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
    Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
    Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacological studies of guanabenz. Effects on the peripheral nervous and other organ systems].
    Ohata K; Murata T; Sakamoto H; Kohno S; Hojo M; Yoshida Y; Nagasaka Y; Akimoto Y; Shimada A; Teramoto N; Tatsumi H
    Nihon Yakurigaku Zasshi; 1983 Jan; 81(1):59-78. PubMed ID: 6852682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological properties of the receptor(s) involved in the 5-hydroxytryptamine-induced contraction of the feline middle cerebral artery.
    Hamel E; Robert JP; Young AR; MacKenzie ET
    J Pharmacol Exp Ther; 1989 Jun; 249(3):879-89. PubMed ID: 2732950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine.
    Cohen ML; Fuller RW
    Life Sci; 1983 Feb; 32(7):711-8. PubMed ID: 6827905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in agonist dissociation constant estimates for 5-HT at 5-HT2-receptors: a problem of acute desensitization?
    Leff P; Martin GR
    Br J Pharmacol; 1988 Oct; 95(2):569-77. PubMed ID: 3228675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-specific stimulant activity of tyramine on isolated intestinal preparations.
    Jamieson DD; Taylor KM
    Agents Actions; 1979 Dec; 9(5-6):422-7. PubMed ID: 546167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structures and pathways of the central nervous system are potentially involved in the serotonergic modulation of gastrointestinal activity.
    Sevcík J; Petrovický P; Růzicka V; Slánský J; Masek K
    Methods Find Exp Clin Pharmacol; 2002 Dec; 24(10):669-73. PubMed ID: 12616959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is desensitization of intestinal 5-hydroxytryptamine receptors an in-vitro phenomenon?
    Hardcastle J; Hardcastle PT; Carstairs JW; Franks CM
    J Pharm Pharmacol; 1994 May; 46(5):322-5. PubMed ID: 8083799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A sensitive method for the assay of 5-hydroxytryptamine. 1957.
    Vane JR
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):142-7; discussion 140-1. PubMed ID: 9142402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.